| MeSH term | MeSH ID | Detail |
|---|---|---|
| Inflammation | D007249 | 119 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Tibial Fractures | D013978 | 4 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Henrion D et al. | Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. | 1997 | Br. J. Pharmacol. | pmid:9146891 |
| Lahoz C et al. | Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. | 1997 | Eur. J. Clin. Invest. | pmid:9352251 |
| Ritter JM et al. | Prostacyclin biosynthesis in essential hypertension before and during treatment. | 1996 | J Hum Hypertens | pmid:8642189 |
| Pancera P et al. | Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8860111 |
| Schaefer WR et al. | Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. | 1996 | Prostaglandins | pmid:8875634 |
| van der Weiden RM et al. | Prostanoid excretion in incipient singleton and twin pregnancies. | 1996 | Am. J. Obstet. Gynecol. | pmid:9065139 |
| Brown NJ et al. | Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin. | 1996 | J. Pharmacol. Exp. Ther. | pmid:8930174 |
| Kimblad PO et al. | Prostanoid release after lung transplantation. | 1996 | J. Heart Lung Transplant. | pmid:8913917 |
| Rossi P et al. | Prostacyclin and thromboxane A2 synthesis are increased in acute lower limb ischaemia. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9014222 |
| Hishinuma T et al. | Analysis of the thromboxane/prostacyclin balance in human urine by gas chromatography/selected ion monitoring: abnormalities in diabetics. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8888357 |